Introduction
Brand name: Astrigine‑50 DT
Manufacturer: Astemax Biotech (assumed, per your context)
Composition: Lamotrigine 50 mg dispersible tablet
Astrigine‑50 DT is an antiepileptic and mood‑stabilizing medication in dispersible tablet form, containing lamotrigine 50 mg per tablet. It is indicated for:
Epilepsy: Adjunctive or monotherapy treatment of partial‑onset seizures and generalised tonic‑clonic seizures, including some forms of refractory epilepsies (e.g., Lennox‑Gastaut‑like conditions).
Bipolar disorder: Maintenance therapy to delay mood episodes, especially depressive‑episode‑predominant bipolar I disorder in adults.
Key features
Dispersible (DT) formulation improves palatability and ease of administration in patients who have difficulty swallowing or need dose flexibility (e.g., paediatric/neuro‑disabled patients).
Astemax can position Astrigine‑50 DT as a neurologist‑ and psychiatrist‑friendly, dispersible lamotrigine tablet for flexible, patient‑centric dosing in epilepsy and bipolar‑related mood‑stabilisation regimens.
